P-glycoprotein-mediated transcellular transport of MDR-reversing agents.

Article Details

Citation

Copy to clipboard

Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T

P-glycoprotein-mediated transcellular transport of MDR-reversing agents.

FEBS Lett. 1993 Jun 7;324(1):99-102.

PubMed ID

8099333 [View in PubMed

]

Abstract

Understanding of the interactions between P-glycoprotein and multidrug resistance (MDR) reversing agents is important in designing more effective MDR modulators. We examined transcellular transport of several MDR modulators by using a drug-sensitive epithelial cell line, LLC-PK1, and its transformant cell line, LLC-GA5-COL300, which expresses human P-glycoprotein on the apical surface. Basal-to-apical transports of azidopine and diltiazem across the LLC-GA5-COL300 monolayer were increased and apical-to-basal transports were decreased compared to those across the LLC-PK1 monolayer, indicating that P-glycoprotein transports azidopine and diltiazem. Movements of nitrendipine and staurosporine across the epithelial monolayer were not affected by P-glycoprotein. These results suggests that some MDR modulators exert their inhibitory effect not only by blocking the initial binding of anticancer drugs but throughout the course of the transport process.

DrugBank Data that Cites this Article

药物转运蛋白

Drug	Transporter	Kind	Organism	Pharmacological Action	Actions
Diltiazem	P-glycoprotein 1	Protein	Humans	Unknown	Substrate Inhibitor	Details